These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38068978)

  • 1. Challenges in Brugada Syndrome Stratification: Investigating
    Tarantino A; Ciconte G; Ghiroldi A; Mastrocinque F; Micaglio E; Boccellino A; Negro G; Piccoli M; Cirillo F; Vicedomini G; Santinelli V; Anastasia L; Pappone C
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico validation revealed the role of SCN5A mutations and their genotype-phenotype correlations in Brugada syndrome.
    Pham HM; Dang DP; Ta TD; Le TP; Phan DP; Trinh HA; Tran TV; Luong TLA; Nguyen HM; Bui TH; Tran TH; Ta TV; Tran VK
    Mol Genet Genomic Med; 2023 Dec; 11(12):e2263. PubMed ID: 37547970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of Two Novel Mutations in
    Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
    Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
    Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome.
    Ishikawa T; Kimoto H; Mishima H; Yamagata K; Ogata S; Aizawa Y; Hayashi K; Morita H; Nakajima T; Nakano Y; Nagase S; Murakoshi N; Kowase S; Ohkubo K; Aiba T; Morimoto S; Ohno S; Kamakura S; Nogami A; Takagi M; Karakachoff M; Dina C; Schott JJ; Yoshiura KI; Horie M; Shimizu W; Nishimura K; Kusano K; Makita N
    Eur Heart J; 2021 Jul; 42(29):2854-2863. PubMed ID: 34219138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole exome sequencing in Brugada and long QT syndromes revealed novel rare and potential pathogenic mutations related to the dysfunction of the cardiac sodium channel.
    Chen J; Li H; Guo S; Yang Z; Sun S; Zeng J; Gou H; Chen Y; Wang F; Lin Y; Huang K; Yue H; Ma Y; Lin Y
    Orphanet J Rare Dis; 2022 Oct; 17(1):394. PubMed ID: 36303204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-cell transcriptomics trajectory and molecular convergence of clinically relevant mutations in Brugada syndrome.
    Tambi R; Abdel Hameid R; Bankapur A; Nassir N; Begum G; Alsheikh-Ali A; Uddin M; Berdiev BK
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1935-H1948. PubMed ID: 33797273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological characterization of a large set of novel variants in the SCN5A-gene: identification of novel LQTS3 and BrS mutations.
    Ortiz-Bonnin B; Rinné S; Moss R; Streit AK; Scharf M; Richter K; Stöber A; Pfeufer A; Seemann G; Kääb S; Beckmann BM; Decher N
    Pflugers Arch; 2016 Aug; 468(8):1375-87. PubMed ID: 27287068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique clinical characteristics and SCN5A mutations in patients with Brugada syndrome in Taiwan.
    Juang JM; Tsai CT; Lin LY; Liu YB; Yu CC; Hwang JJ; Chen JJ; Chiu FC; Chen WJ; Tseng CD; Chiang FT; Yeh HM; Sherri Yeh SF; Lai LP; Lin JL
    J Formos Med Assoc; 2015 Jul; 114(7):620-6. PubMed ID: 26154754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SCN5A Gene Is a Predictor of Phenotype Severity in Brugada Syndrome: A Comprehensive Literature Review.
    Deica AV; Paduraru LF; Paduraru DN; Andronic O
    Med Princ Pract; 2023; 32(1):1-8. PubMed ID: 36446338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of SCN5A coding and non-coding sequences in Brugada syndrome onset: What's behind the scenes?
    Daimi H; Khelil AH; Neji A; Ben Hamda K; Maaoui S; Aranega A; Be Chibani J; Franco D
    Biomed J; 2019 Aug; 42(4):252-260. PubMed ID: 31627867
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Wijeyeratne YD; Tanck MW; Mizusawa Y; Batchvarov V; Barc J; Crotti L; Bos JM; Tester DJ; Muir A; Veltmann C; Ohno S; Page SP; Galvin J; Tadros R; Muggenthaler M; Raju H; Denjoy I; Schott JJ; Gourraud JB; Skoric-Milosavljevic D; Nannenberg EA; Redon R; Papadakis M; Kyndt F; Dagradi F; Castelletti S; Torchio M; Meitinger T; Lichtner P; Ishikawa T; Wilde AAM; Takahashi K; Sharma S; Roden DM; Borggrefe MM; McKeown PP; Shimizu W; Horie M; Makita N; Aiba T; Ackerman MJ; Schwartz PJ; Probst V; Bezzina CR; Behr ER
    Circ Genom Precis Med; 2020 Dec; 13(6):e002911. PubMed ID: 33164571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    Zhang ZH; Barajas-Martínez H; Xia H; Li B; Capra JA; Clatot J; Chen GX; Chen X; Yang B; Jiang H; Tse G; Aizawa Y; Gollob MH; Scheinman M; Antzelevitch C; Hu D
    J Am Coll Cardiol; 2021 Oct; 78(16):1603-1617. PubMed ID: 34649698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy.
    Curcio A; Malovini A; Mazzanti A; Memmi M; Gambelli P; La Rosa F; Bloise R; Indolfi C; Bellazzi R; Napolitano C
    Heart Rhythm; 2021 Oct; 18(10):1698-1706. PubMed ID: 34245912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-phenotype relationship and risk stratification in loss-of-function SCN5A mutation carriers.
    Robyns T; Nuyens D; Vandenberk B; Kuiperi C; Corveleyn A; Breckpot J; Garweg C; Ector J; Willems R
    Ann Noninvasive Electrocardiol; 2018 Sep; 23(5):e12548. PubMed ID: 29709101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.